Study description
A multicentric, retrospective, non-interventional, cohort study to compare the safety and use of androgen receptor pathway inhibitors in men with metastatic hormone-sensitive prostate cancer using data from remote monitoring and medical files.
Key results
Interim analysis: 337 eligible – analysis ongoing
